Among patients with POD1 PTH levels of 15–19 pg/ml, together with 6 a.m. POD1 calcium levels ≥ 2.0 mmol/l, the risk of symptomatic hypocalcaemia and need for intravenous calcium was 5.4% (3/55). This evidence concerns the gene PTH and Hypocalcemia.